デフォルト表紙
市場調査レポート
商品コード
1023409

ELISpotおよびFluoroSpotアッセイの世界市場:製品、用途、エンドユーザー、地域別(北米、欧州、アジア太平洋、中南米、中東・アフリカ)動向分析、競合市場シェア、予測(2017年~2027年)

Global ELISpot and FluoroSpot Assays Market, By Product, By Application, By End-User, By Region (North America, Europe, Asia-Pacific, Latin America, Middle-East & Africa Trend Analysis, Competitive Market Share & Forecast, 2017-2027

出版日: | 発行: Blueweave Consulting & Research Private Limited | ページ情報: 英文 200 Pages | 納期: お問合せ

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=116.46円
ELISpotおよびFluoroSpotアッセイの世界市場:製品、用途、エンドユーザー、地域別(北米、欧州、アジア太平洋、中南米、中東・アフリカ)動向分析、競合市場シェア、予測(2017年~2027年)
出版日: 2021年08月13日
発行: Blueweave Consulting & Research Private Limited
ページ情報: 英文 200 Pages
納期: お問合せ
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のELISpotおよびFluoroSpotアッセイの市場規模は、2020年に1億6,710万米ドルとなりました。同市場は、20.6%のCAGRで成長する見通しで、2027年には約6億540万米ドルの収益に達すると予測されています。同市場の成長は、慢性疾患の増加、複数の感染症の出現、感染症予防のためのワクチン開発の必要性の高まりなど、いくつかの要因に起因しています。さらに、メーカーによるELISpotおよびFluoroSpotアッセイキットの技術的進歩も、予測期間中の市場成長を促進すると予測されています。

ELISPotおよびFluoroSpotアッセイは、免疫系細胞の主要な細胞機能を測定するために研究機関で広く使用されており、病院、診療所、バイオ医薬品企業での需要増加が非常に顕著です。ELISpotおよびFluoroSpotアッセイは、モニタリング、移植、ワクチン開発や、病原体に対する免疫システムの反応の追跡などにも使用されており、幅広い用途で使用により、予測期間中の需要拡大が見込まれています。

当レポートは、世界のELISpotおよびFluoroSpotアッセイ市場について調査しており、市場の成長性、今後の動向、統計などの情報を提供しています。また、市場規模や予測、市場の成長要因、課題、製品・用途・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査フレームワーク

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界のELISpotおよびFluoroSpotアッセイ市場-業界考察

  • DROC分析
    • 成長要因
    • 抑制要因
    • 市場機会
    • 課題
  • 最近の開発/技術的情勢
  • 規制の枠組み
  • ポーターのファイブフォース分析
  • バリューチェーン分析
  • 戦略的展望

第5章 世界のELISpotおよびFluoroSpotアッセイ市場概要

  • 市場推計と売上別予測(2017年~2027年)
    • 売上別
  • 市場シェアと予測
    • 製品別
      • アッセイキット
      • 分析器
      • 付属品
    • 用途別
      • 診断用途
      • 調査用途
    • エンドユーザー別
      • 病院とクリニック
      • 研究機関
      • バイオ製薬企業
    • 地域別
      • 北米
      • 欧州
      • アジア太平洋(APAC)
      • ラテンアメリカ(LATAM)
      • 中東・アフリカ(MEA)

第6章 北米の市場概要

  • 市場規模と予測
    • 売上別(2017年~2027年)
  • 市場シェアと予測
    • 製品別
    • 用途別
    • エンドユーザー別
    • 国別
      • 米国
      • カナダ

第7章 欧州の市場概要

  • 市場規模と予測
    • 売上別(2017年~2027年)
  • 市場シェアと予測
    • 製品別
    • 用途別
    • エンドユーザー別
    • 国別
      • ドイツ
      • 英国
      • フランス
      • イタリア
      • スペイン
      • ロシア
      • オランダ
      • その他

第8章 アジア太平洋の市場概要

  • 市場規模と予測
    • 売上別(2017年~2027年)
  • 市場シェアと予測
    • 製品別
    • 用途別
    • エンドユーザー別
    • 国別
      • 中国
      • インド
      • 日本
      • 韓国
      • その他

第9章 ラテンアメリカの市場概要

  • 市場規模と予測
    • 売上別(2017年~2027年)
  • 市場シェアと予測
    • 製品別
    • 用途別
    • エンドユーザー別
    • 国別
      • メキシコ
      • ブラジル
      • その他

第10章 中東・アフリカの市場概要

  • 市場規模と予測
    • 売上別(2017年~2027年)
  • 市場シェアと予測
    • 製品別
    • 用途別
    • エンドユーザー別
    • 国別
      • サウジアラビア
      • アラブ首長国連邦
      • 南アフリカ
      • その他

第11章 競合情勢

  • 主な生産者と製品リスト
  • 市場シェア/ランキング分析(2020)
  • パラメータ操作による競合ベンチマーキング

第12章 COVID-19の影響

  • 将来の影響
  • COVID-19の間の主な発展
  • 市場への影響
    • 別のシナリオ
    • 企業への影響
  • 地域への影響

第13章 企業プロファイル概要(企業概要、財務マトリックス、主要製品の情勢、主要役員、主要競合、連絡先、および戦略的展望)

  • Bio-Techne Corporation
  • Bio-Connect B.V.
  • Autoimmun Diagnostika GmbH
  • Mabtech AB
  • U-Cytech Biosciences
  • Oxford Immunotec
  • Lophius Biosciences GmbH
  • Abcam
  • Cellular Technologies Limited
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific
  • Elabscience
  • Biotech Investissement Group
  • Covance(LabCorp)
  • Other Prominent Players

第14章 主な戦略的提言

図表

List of Figures

  • Fig: Global Elispot and Fluorospot Assay Segmentation
  • Fig: Global Elispot and Fluorospot Assay Market Value Chain Analysis,
  • Fig: Company Market Share Analysis, 2020
  • Fig: Global Elispot and Fluorospot Assay Market Size, By Value (USD Million), 2017-2027
  • Fig: Global Elispot and Fluorospot Assay Market Share (%), By Product, By Value, 2017-2027
  • Fig: Global Elispot and Fluorospot Assay Market Share (%), By Application, By Value, 2017-2027
  • Fig: Global Elispot and Fluorospot Assay Market Share (%), By End-User, By Value, 2017-2027
  • Fig: Global Elispot and Fluorospot Assay Market Share (%), By Country, By Value, 2017-2027
  • Fig: North America Elispot and Fluorospot Assay Market Size, By Value (USD Million), 2017-2027
  • Fig: North America Elispot and Fluorospot Assay Market Share (%), By Product, By Value, 2017-2027
  • Fig: North America Elispot and Fluorospot Assay Market Share (%), By Application, By Value, 2017-2027
  • Fig: North America Elispot and Fluorospot Assay Market Share (%), By End-User, By Value, 2017-2027
  • Fig: North America Elispot and Fluorospot Assay Market Share (%), By Country, By Value, 2017-2027
  • Fig: Europe Elispot and Fluorospot Assay Market Size, By Value (USD Million), 2017-2027
  • Fig: Europe Elispot and Fluorospot Assay Market Share (%), By Product, By Value, 2017-2027
  • Fig: Europe Elispot and Fluorospot Assay Market Share (%), By Application, By Value, 2017-2027
  • Fig: Europe Elispot and Fluorospot Assay Market Share (%), By End-User, By Value, 2017-2027
  • Fig: Europe Elispot and Fluorospot Assay Market Share (%), By Country, By Value, 2017-2027
  • Fig: the Asia-Pacific Elispot and Fluorospot Assay Market Size, By Value (USD Million), 2017-2027
  • Fig: the Asia-Pacific Elispot and Fluorospot Assay Market Share (%), By Product, By Value, 2017-2027
  • Fig: the Asia-Pacific Elispot and Fluorospot Assay Market Share (%), By Application, By Value, 2017-2027
  • Fig: the Asia-Pacific Elispot and Fluorospot Assay Market Share (%), By End-User, By Value, 2017-2027
  • Fig: the Asia-Pacific Elispot and Fluorospot Assay Market Share (%), By Country, By Value, 2017-2027
  • Fig: Latin America Elispot and Fluorospot Assay Market Size, By Value (USD Million), 2017-2027
  • Fig: Latin America Elispot and Fluorospot Assay Market Share (%), By Product, By Value, 2017-2027
  • Fig: Latin America Elispot and Fluorospot Assay Market Share (%), By Application, By Value, 2017-2027
  • Fig: Latin America Elispot and Fluorospot Assay Market Share (%), By End-User, By Value, 2017-2027
  • Fig: Latin America Elispot and Fluorospot Assay Market Share (%), By Country, By Value, 2017-2027
  • Fig: Middle East & Africa Elispot and Fluorospot Assay Market Size, By Value (USD Million), 2017-2027
  • Fig: Middle East & Africa Elispot and Fluorospot Assay Market Share (%), By Product, By Value, 2017-2027
  • Fig: Middle East & Africa Elispot and Fluorospot Assay Market Share (%), By Application, By Value, 2017-2027
  • Fig: Middle East & Africa Elispot and Fluorospot Assay Market Share (%), By End-User, By Value, 2017-2027
  • Fig: Middle East & Africa Elispot and Fluorospot Assay Market Share (%), By Region, By Value, 2017-2027

List of Tables

  • Table: Global Elispot and Fluorospot Assay Market Size, By Product, By Value, 2017-2027
  • Table: Global Elispot and Fluorospot Assay Market Size, By Application, By Value (USD Million), 2017-2027
  • Table: Global Elispot and Fluorospot Assay Market Size, By End-User, By Value (USD Million), 2017-2027
  • Table: Global Elispot and Fluorospot Assay Market Size, By Region, By Value (USD Million), 2017-2027
  • Table: North America Elispot and Fluorospot Assay Market Size, By Product, By Value (USD Million), 2017-2027
  • Table: North America Elispot and Fluorospot Assay Market Size, By Application, By Value (USD Million), 2017-2027
  • Table: North America Elispot and Fluorospot Assay Market Size, By End-User, By Value (USD Million), 2017-2027
  • Table: North America Elispot and Fluorospot Assay Market Size, By Country, By Value (USD Million), 2017-2027
  • Table: Europe Elispot and Fluorospot Assay Market Size, By Product, By Value (USD Million), 2017-2027
  • Table: Europe Elispot and Fluorospot Assay Market Size, By Application, By Value (USD Million), 2017-2027
  • Table: Europe Elispot and Fluorospot Assay Market Size, By End-User, By Value (USD Million), 2017-2027
  • Table: Europe Elispot and Fluorospot Assay Market Size, By Country, By Value (USD Million), 2017-2027
  • Table: the Asia-Pacific Elispot and Fluorospot Assay Market Size, By Product, By Value (USD Million), 2017-2027
  • Table: the Asia-Pacific Elispot and Fluorospot Assay Market Size, By Application, By Value (USD Million), 2017-2027
  • Table: the Asia-Pacific Elispot and Fluorospot Assay Market Size, By End-User, By Value (USD Million), 2017-2027
  • Table: the Asia-Pacific Elispot and Fluorospot Assay Market Size, By Country, By Value (USD Million), 2017-2027
  • Table: Latin America Elispot and Fluorospot Assay Market Size, By Product, By Value (USD Million), 2017-2027
  • Table: Latin America Elispot and Fluorospot Assay Market Size, By Application, By Value (USD Million), 2017-2027
  • Table: Latin America Elispot and Fluorospot Assay Market Size, By End-User, By Value (USD Million), 2017-2027
  • Table: Latin America Elispot and Fluorospot Assay Market Size, By Country, By Value (USD Million), 2017-2027
  • Table: The Middle-East & Africa Elispot and Fluorospot Assay Market Size, By Product, By Value (USD Million), 2017-2027
  • Table: The Middle-East & Africa Elispot and Fluorospot Assay Market Size, By Application, By Value (USD Million), 2017-2027
  • Table: The Middle-East & Africa Elispot and Fluorospot Assay Market Size, By End-User, By Value (USD Million), 2017-2027
  • Table: The Middle-East & Africa Elispot and Fluorospot Assay Market Size, By Country, By Value (USD Million), 2017-2027
  • Table: Bio-Techne Corporation Financial Analysis
  • Table: Bio-Techne Corporation Business Overview
  • Table: Bio-Connect B.V. Financial Analysis
  • Table: Bio-Connect B.V. Business Overview
  • Table: Autoimmun Diagnostika GmbH Financial Analysis
  • Table: Autoimmun Diagnostika GmbH Business Overview
  • Table: Mabtech AB Financial Analysis
  • Table: Mabtech AB Business Overview
  • Table: U-Cytech Biosciences Financial Analysis
  • Table: U-Cytech Biosciences Business Overview
  • Table: Oxford Immunotec Financial Analysis
  • Table: Oxford Immunotec Business Overview
  • Table: Lophius Biosciences GmbH Financial Analysis
  • Table: Lophius Biosciences GmbH Business Overview
  • Table: Abcam Financial Analysis
  • Table: Abcam Business Overview
  • Table: Cellular Technologies Limited Financial Analysis
  • Table: Cellular Technologies Limited Business Overview
  • Table: Becton, Dickinson and Company Financial Analysis
  • Table: Becton, Dickinson and Company Business Overview
  • Table: Thermo Fisher Scientific Financial Analysis
  • Table: Thermo Fisher Scientific Financial Analysis
  • Table: Elabscience Financial Analysis
  • Table: Elabscience Business Overview
  • Table: Biotech Investissement Group Financial Analysis
  • Table: Biotech Investissement Group Business Overview
  • Table: Covance (LabCorp) Financial Analysis
  • Table: Covance (LabCorp) Business Overview
目次
Product Code: BWC2117

Global ELISpot and FluoroSpot Assays Market Gaining Momentum: Projected to Touch USD 605.4 Million By 2027, Growing at the CAGR of 20.6% during the Forecast Period

A recent study conducted by the strategic consulting and market research firm BlueWeave Consulting revealed that the global ELISpot and FluoroSpot assays market was worth USD 167.1 million in the year 2020. The study also states that the market is estimated to grow at the CAGR of 20.6%, earning revenue of around USD 605.4 million by the end of 2027. The growth of the market can be attributed to several factors such as the growing prevalence of chronic diseases, the emergence of several infectious diseases, and the surging need for developing vaccines for preventing infectious diseases, among others. Furthermore, technological advancements in the ELISpot and FluoroSpot assay kits by manufacturers are also projected to drive the growth of the global ELISpot and FluoroSpot assays marketduring the forecast period.

Wide Range of Applicability Of ELISpot And FluoroSpot Driving Market Growth

The ELISPot and FluoroSpot assays are widely used in research institutes to measure key cellular functions of immune system cells.The demand for these assays is very prominent in hospitals, clinics, and biopharmaceutical companies because of the wide applicability it has to offer. ELISpot and FluoroSpot assays are involved in the examination of the Th1/Th2 responses, cancerology, infectious diseases, viral infection monitoring and diseases, autoimmune diseases and transplantation, vaccine development, etc. They are also used in tracking immune system responses against pathogens. Due to such a wide range of applications and usage, the demand for ELISPot and FluoroSpot assays is likely to grow during the forecast period.

Potential ToBecoming Standard Testing Method Across Laboratories

ELISpot and FluoroSpot assays have high usage in clinical trials, especially in developing countries due to their cost-effectiveness. In addition to providing a quantitative conclusion, they also elaborate on the detailed nature of immune responses to cytokines.Furthermore, for performing clinical trials by ELISpot and Fluorospot assays, the laboratories do not require expensive or high-end instrumentation and equipment. All these factors make ELISpot and FluoroSpot assays a very convenient technique for carrying out clinical trials. As a result, they are being increasingly adopted as a standard testing method across laboratories around the world.

Hospital and Clinical Laboratories Will Lead the ELISpot And FluoroSpot Assays Market

Based on end-user, the global ELISpot and FluoroSpot assays market is categorized into hospitals & clinics, research institutes, and biopharmaceutical companies. Hospitals and clinics around the world have a very prominent demand for the ELISpot and Fluorospot assays kits as they are very effective and are widely used in viral infection monitoring and treatment. One of the factors influencing the surging demand for ELISpot and FluoroSpot assays is the increasing number of patients seeking treatment for chronic and infectious diseases.

Global ELISpot and FluoroSpot Assays Market - Regional Insights

Geographically, the global ELISpot and FluoroSpot assays market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle-East & Africa. North America holds the largest market share due to the high prevalence of chronic as well as infectious diseases. The growing patient pool, along with the continued support of government and private institutions to research institutes by funding them significantly, contribute to the growth of the ELISpot and FluoroSpot assays in this region.However, the Asia-Pacific region is projected to witness the highest CAGR in the forecast period. The population of emerging economies is much higher as compared to the developed countries, due to which the percentage of population suffering from various chronic and infectious diseases is also high. As a result, the ELISpot and FluoroSpot assays market is gaining significant traction in the Asia-Pacific region. Moreover, China is projected to remain among the fastest-growing markets in the APAC region.

Impact of COVID-19 on Global ELISpot and FluoroSpot assays Market

Among the main reasons for this spike in the growth of the markets for ELISpot and FluoroSpot is the sudden outbreak of COVID-19 and its spread worldwide.Vaccine development became imperative as the virus spread rapidly and claimed lives every day.Thus, the competition between research institutes as well as biopharmaceutical companies for developing the first vaccination kit has fueled the market demand for the ELISpot and FluoroSpot assay kits. However, during the initial phase of the pandemic, companies had to experience short-term operational issues due to supply chain constraints, as well as a lack of access to the sites in China, the US, and Germany.

Competitive Landscape

The leading market players of the global ELISpot and FluoroSpot assays market are Bio-Techne Corporation, Bio-Connect B.V., AutoimmunDiagnostika GmbH, Mabtech AB, U-Cytech Biosciences, Oxford Immunotec, Lophius Biosciences GmbH, Abcam, Cellular Technologies Limited, Becton, Dickinson and Company, Thermo Fisher Scientific, Elabscience, Biotech Investissement Group, Covance (LabCorp), and other prominent players.

The market is dominated by global players who cover a high percentage of the market. The industry participants have been consistently investing and focusing on intensive research and development for innovating and advancing their products which can offer early and accurate diagnosis of diseases. Furthermore, the adoption of competitive strategies like partnerships, joint ventures, product approvals, and launches is also very prominent in this market.

Don't miss the business opportunity of the global ELISpot and FluoroSpot assays market. Consult our analysts to gain crucial insights and facilitate your business growth.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the global ELISpot and FluoroSpot assays market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends of the global ELISpot and FluoroSpot assays market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Research Methodology

  • 2.1. Qualitative Research
    • 2.1.1. Primary and Secondary Sources
  • 2.2. Quantitative Research
    • 2.2.1. Primary and Secondary Sources
  • 2.3. Breakdown of Primary Research Respondents
    • 2.3.1. Secondary Research
    • 2.3.2. Primary Research
  • 2.4. Breakdown of Primary Research Respondents, By Industry Participants
  • 2.5. Key Questionnaire asked during Primary Interviews
  • 2.6. Key Primary Responses
  • 2.7. Market Size Estimation
  • 2.8. Assumption for the Study
  • 2.9. Market Breakdown & Data Triangulation

3. Executive Summary

4. Global Elispot and Fluorospot Assay Market - Industry Insights

  • 4.1. DROC Analysis
    • 4.1.1. Growth Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunity
    • 4.1.4. Challenges
  • 4.2. Recent Developments / Technical Landscape
  • 4.3. Regulatory Framework
  • 4.4. Porter's Five Forces Analysis
  • 4.5. Value Chain Analysis
  • 4.6. Strategic Outlook

5. Global Elispot and Fluorospot Assay Market Overview

  • 5.1. Market Estimates & Forecast by Value, 2017-2027
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product
      • 5.2.1.1. Assay Kits
      • 5.2.1.2. Analyzers
      • 5.2.1.3. Ancillary Products
    • 5.2.2. By Application
      • 5.2.2.1. Diagnostic Applications
      • 5.2.2.1.1. Infectious Diseases
      • 5.2.2.1.2. Transplants
      • 5.2.2.2. Research Applications
      • 5.2.2.2.1. Vaccine Development
      • 5.2.2.2.2. Clinical Trials
      • 5.2.2.2.3. Cancer Research
    • 5.2.3. By End-User
      • 5.2.3.1. Hospitals & Clinics
      • 5.2.3.2. Research Institutes
      • 5.2.3.3. Biopharmaceutical Companies
    • 5.2.4. By Region
      • 5.2.4.1. North America
      • 5.2.4.2. Europe
      • 5.2.4.3. Asia-Pacific (APAC)
      • 5.2.4.4. Latin America (LATAM)
      • 5.2.4.5. Middle-East & Africa (MEA)

6. North America Elispot and Fluorospot Assay Market Overview

  • 6.1. Market Size and Forecast
    • 6.1.1. By Value (USD Million), 2017-2027
  • 6.2. Market Share and Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By End-User
    • 6.2.4. By Country
      • 6.2.4.1. U.S.
      • 6.2.4.2. Canada

7. Europe Elispot and Fluorospot Assay Market Overview

  • 7.1. Market Size and Forecast
    • 7.1.1. By Value (USD Million), 2017-2027
  • 7.2. Market Share and Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By End-User
    • 7.2.4. By Country
      • 7.2.4.1. Germany
      • 7.2.4.2. U.K.
      • 7.2.4.3. France
      • 7.2.4.4. Italy
      • 7.2.4.5. Spain
      • 7.2.4.6. Russia
      • 7.2.4.7. Netherlands
      • 7.2.4.8. Rest of Europe

8. APAC Elispot and Fluorospot Assay Market Overview

  • 8.1. Market Size and Forecast
    • 8.1.1. By Value (USD Million), 2017-2027
  • 8.2. Market Share and Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. China
      • 8.2.4.2. India
      • 8.2.4.3. Japan
      • 8.2.4.4. South Korea
      • 8.2.4.5. Rest of APAC

9. LATAM Elispot and Fluorospot Assay Market Overview

  • 9.1. Market Size and Forecast
    • 9.1.1. By Value (USD Million), 2017-2027
  • 9.2. Market Share and Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By End-User
    • 9.2.4. By Country
      • 9.2.4.1. Mexico
      • 9.2.4.2. Brazil
      • 9.2.4.3. Rest of LATAM

10. MEA Elispot and Fluorospot Assay Market Overview

  • 10.1. Market Size and Forecast
    • 10.1.1. By Value (USD Million), 2017-2027
  • 10.2. Market Share and Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By End-User
    • 10.2.4. By Country
      • 10.2.4.1. Saudi Arabia
      • 10.2.4.2. UAE
      • 10.2.4.3. South Africa
      • 10.2.4.4. Rest of Europe

11. Competitive Landscape

    • 11.1.1. List of Key Producers and Their Offerings
    • 11.1.2. Market Share / Ranking Analysis (2020)
    • 11.1.3. Competitive Benchmarking, By Operating Parameters

12. COVID-19 Impact

  • 12.1. Future Impact
  • 12.2. Key Developments during COVID-19
  • 12.3. Impact on Market
    • 12.3.1. Different Scenario
    • 12.3.2. Impact on Companies
  • 12.4. Regional Impact

13. Company Profiles (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *

  • 13.1. Bio-Techne Corporation
  • 13.2. Bio-Connect B.V.
  • 13.3. Autoimmun Diagnostika GmbH
  • 13.4. Mabtech AB
  • 13.5. U-Cytech Biosciences
  • 13.6. Oxford Immunotec
  • 13.7. Lophius Biosciences GmbH
  • 13.8. Abcam
  • 13.9. Cellular Technologies Limited
  • 13.10. Becton, Dickinson and Company
  • 13.11. Thermo Fisher Scientific
  • 13.12. Elabscience
  • 13.13. Biotech Investissement Group
  • 13.14. Covance (LabCorp)
  • 13.15. Other Prominent Players

14. Key Strategic Recommendations

* Financial information of non-listed Companies will be provided as per availability

**The segmentation and the companies are subjected to modifications based on in-depth study during the final deliverable.